SCHEMBL22997803

SCHEMBL22997803

Cn1cnc([S+]([O-])N2CCC(Nc3ncc(C(F)(F)F)c(Cl)n3)CC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 18/20 0.42
▸ CDK2 P24941 18/20 0.42
▸ CDK1 P06493 14/20 0.42
▸ CCNB1 P14635 14/20 0.42
▸ CCND1 P24385 13/20 0.42
▸ CDK6 Q00534 13/20 0.42
▸ CDK4 P11802 12/20 0.42
▸ CCND3 P30281 12/20 0.42
▸ CCNT1 O60563 6/20 0.42
▸ CDK7 P50613 6/20 0.42
▸ CDK9 P50750 6/20 0.42
▸ CCNH P51946 6/20 0.42
▸ MNAT1 P51948 6/20 0.42
▸ ULK1 O75385 1/20 0.40
▸ MAPK3 P27361 1/20 0.34
▸ CCNB2 O95067 1/20 0.34
▸ CCNE2 O96020 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ CCNB3 Q8WWL7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22997813 0.77 CDK7 (0.53) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL30449148 0.77 CCNE1 (0.67) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL22900798 0.77 CCNE1 (0.67) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL22997699 0.77 CDK7 (0.41) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL23001264 0.74 ULK1 (0.49) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL11907283 0.72 ULK1 (0.71) CCNE1CDK2CCNT1CDK7CDK9
SCHEMBL26045352 0.72 ULK1 (0.67) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL22901105 0.72 CCNE1 (0.65) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL29631651 0.72 CCNE1 (0.65) CCNE1CDK2CDK1CCNB1CCND1
SCHEMBL18765976 0.72 MAPK1 (0.57) CCNE1CDK2CDK1CCNB1ULK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021030537-A1 IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS INCYTE CORPORATION (US) 2021-02-18 — — WO disclosed
Send feedback